Nathaniel S. Gardiner - Feb 26, 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Chief Legal Officer
Signature
/s/ Nathaniel S. Gardiner
Stock symbol
ENTA
Transactions as of
Feb 26, 2024
Transactions value $
$46,631
Form type
4
Date filed
2/27/2024, 06:31 PM
Previous filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Options Exercise $46.6K +5.19K +7.36% $8.99 75.7K Feb 26, 2024 Direct
holding ENTA Common Stock 35.9K Feb 26, 2024 By grantor retained annuity trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTA Stock Option (Right to Buy) Options Exercise $0 -5.19K -6.25% $0.00 77.8K Feb 26, 2024 Common Stock 5.19K $8.99 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by grantor retained annuity trusts created by the reporting person for the benefit of himself and his two adult children.
F2 Such option became or will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 22, 2023).